Case Western Reserve University School of Medicine, Cleveland, Ohio
Center for Value-Based Care Research, Cleveland Clinic, Cleveland, Ohio.
Ann Fam Med. 2018 Jul;16(4):349-352. doi: 10.1370/afm.2244.
This qualitative study examines to what extent and why physicans still prescribe self-monitoring of blood glucose (SMBG) in patients with non-insulin-treated type 2 diabetes (NITT2D) when the evidence shows it increases cost without improving hemoglobin A (HbA), general well being, or health-related quality of life. Semistructured phone interviews with 17 primary care physicians indicated that the majority continue to recommend routine self-monitoring of blood glucose due to a compelling belief in its ability to promote the lifestyle changes needed for glycemic control. Targeting physician beliefs about the effectiveness of self-monitoring of blood glucose, and designing robust interventions accordingly, may help reduce this practice.
本定性研究考察了在证据表明自我监测血糖（SMBG）并不能改善血红蛋白 A（HbA）、整体健康状况或健康相关生活质量，反而增加成本的情况下，医生为何仍会建议非胰岛素治疗的 2 型糖尿病（NITT2D）患者进行自我监测血糖。对 17 名初级保健医生的半结构化电话访谈表明，由于坚信自我监测血糖能够促进血糖控制所需的生活方式改变，大多数医生仍建议常规进行自我监测血糖。针对医生对自我监测血糖有效性的信念，并相应地设计强有力的干预措施，可能有助于减少这种做法。
